Devam Parghi, MD

Internal Medicine Resident Physician (PGY1)

[Devam Parghi, MD @Dpparghi1]

@SocietyHospMed @ACOMEDU #shmWiregrass #ACOMposterday #WGCQI Hi, I am Devam Parghi, PGY1 Southeast Health IM Residency. The crux behind this project is - if CKD patients have regular RFTs documented; disease can be followed and nephrotoxins avoided thus slowing CKD progression

[Devam Parghi, MD @Dpparghi1]

@SheilaH16237324 Thankyou Dr Hernandez !

[Devam Parghi, MD @Dpparghi1]

@SocietyHospMed @ACOMEDU #shmWiregrass #ACOMposterday #WGCQI Hi, I am Devam Parghi, PGY1 Southeast Health IM Residency. The crux behind this project is - if CKD patients have regular RFTs documented; disease can be followed and nephrotoxins avoided thus slowing CKD progression

[Devam Parghi, MD @Dpparghi1]

@AriailSchmitzDO @SocietyHospMed @ACOMEDU Thankyou Dr Schmitz, actually - pre intervention - from the 918 patients studied -> 9.5% population were prescribed NSAIDs that decreased to 7.4% of the 1313 patients studied post intervention. So yes, a slight overall decrease in NSAIDs prescription aas found as well.

[Devam Parghi, MD @Dpparghi1]

@SocietyHospMed @ACOMEDU #shmWiregrass #ACOMposterday #WGCQI Hi, I am Devam Parghi, PGY1 Southeast Health IM Residency. The crux behind this project is - if CKD patients have regular RFTs documented; disease can be followed and nephrotoxins avoided thus slowing CKD progression